Paragon Therapeutics, Inc.
Hussam Shaheen possesses extensive experience in biotherapeutics and research leadership, currently serving as Head of Research and Senior Vice President at Paragon Therapeutics, Inc. since October 2021. Previously, Hussam held the position of Director of Antibody Discovery and Engineering at Pandion Therapeutics, a subsidiary of Merck & Co., from February 2020 to October 2023, and worked at Merck from August 2012 to February 2020 as Principal Scientist in Biologics Discovery. Hussam's early career includes a role as Research Scientist II at Avon Products, focusing on skin aging research, and a postdoctoral fellowship at Ohio State University, which involved significant contributions to the understanding of tRNA nuclear transport. Hussam earned a Ph.D. in Biochemistry and Molecular Biology from Pennsylvania State University College of Medicine and a Bachelor of Science in Biochemistry from Texas Tech University.
This person is not in any teams
This person is not in any offices
Paragon Therapeutics, Inc.
Paragon Therapeutics, Inc. is a biotechnology company dedicated to discovering and developing best-in-class biologics for patients with high unmet needs. Our collaborative team of innovators has deep expertise in biologics engineering and development and a passion to tackle some of the toughest disease areas and improve quality of life for patients. If you’re eager to help shape the next generation of biologic treatments, join us! Check out our open positions and learn more at paragontherapeutics.com.